OHSU-developed vaccine shows promise for cancer prevention

Researchers discover vaccine originally created for HIV may also combat cancer

By Angela Yeager May 28, 2024 Portland, Oregon

Downloads

In a new study, Klaus Früh, Ph.D., left, Louis Picker, M.D., and Scott Hansen, Ph.D., all in OHSU’s Vaccine & Gene Therapy Institute, show that their platform for cytomegalovirus-based vaccines shows promise as a “shield” against cancer. (OHSU/Christine Torres Hicks)

Louis Picker, M.D.

Louis Picker, M.D., professor in OHSU’s Vaccine & Gene Therapy Institute, investigates the potential of cytomegalovirus-based vaccines. With colleagues Klaus Früh, Ph.D., and Scott Hansen, Ph.D., both in VGTI, they have found their vaccine platform shows promise as a “shield” against cancer.

Scott Hansen Ph.D.

Scott Hansen, Ph.D., at the Vaccine and Gene Therapy Institute. (OHSU)

Klaus Früh, Ph.D.

Klaus Früh, Ph.D., professor in OHSU’s Vaccine & Gene Therapy Institute, investigates the potential of cytomegalovirus-based vaccines. With colleagues Louis Picker, M.D., and Scott Hansen, Ph.D., both in VGTI, they have found their vaccine platform shows promise as a “shield” against cancer. (OHSU/Christine Torres Hicks)